Skip to content
Facilities by project stage
OmniaBio in the News
OmniaBio celebrates the beginning of construction.
December 1, 2022
Resolution Therapeutics and CCRM sign collaboration agreement, with work to be executed at OmniaBio.
NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada.